Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Philogen
Woman and Man Max 99 years
Philogen S.p.A
Update Il y a 4 ans
Dose definition and activity evaluation study of the tumor-targeting human L19IL2 monoclonal antibody-cytokine fusion protein in combination with Dacarbazine in patients with metastatic melanoma
Phase IIa part: - To establish the recommended dose (RD) of L19IL2 when administered in combination with a fixed dose of DTIC in patients with metastatic melanoma, the preliminary tolerability profil...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Philogen S.p.A
Update Il y a 4 ans
A prospective non-randomized study of 131I-L19SIP Radioimmunotherapy (RIT) in combination with Whole Brain Radiation Therapy (WBRT) in patients with multiple brain metastases from solid tumors
To evaluate the safety of the administration of radioimmunotherapy with 131I-L19SIP combined with whole brain radiation treatment (the standard treatment)and to determine the selective uptake of the s...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Philogen S.p.A
Update Il y a 4 ans
A DOSE FINDING PHARMACOKINETIC STUDY OF THE TUMOUR TARGETING HUMAN L19IL2 MONOCLONAL ANTIBODY CYTOKINE FUSION PROTEIN IN PATIENTS WITH ADVANCED SOLID TUMOURS
Country
None
organs
None
Specialty
None
Closed trial
More information
Previous
1
2